Can Older Dogs Safely Take NAD+ Long Term?

The first thing I notice in an older dog isn’t usually dramatic. It’s a half-second longer to get up from the rug, or a stair he used to take at a trot that he now takes one at a time. Those small shifts are why I’ve stopped treating aging as an event and started treating it as information — a slow accumulation of data points that, added together, tell you where a dog actually is. NAD+ supplementation gets asked about in that context more than almost anything else right now, usually with the same underlying question: is this something I can give my dog for years, or just a phase?

What NAD+ Actually Does at the Cellular Level

Nicotinamide adenine dinucleotide is a coenzyme every cell needs to run basic energy metabolism and DNA repair. Levels decline with age in essentially every species studied, and that decline is one of the more consistent biological markers of getting older. Supplementing with a precursor like nicotinamide riboside (NR) doesn’t add NAD+ directly — the body converts it through a couple of enzymatic steps. That’s a meaningful distinction, because it means dose, absorption, and individual metabolism all affect how much of a bump a given dog actually gets, and none of that is fully mapped out for canines yet.

A 2024 randomized controlled trial published in Scientific Reports looked at a senolytic-and-NAD+-precursor combination in senior dogs and found improved owner-assessed cognitive function over the study period. That’s a real, peer-reviewed data point in dogs specifically, which is rarer than it should be in this category — most of the safety and dosing picture still comes from PMC: human trials, like the randomized, placebo-controlled study of long-term NIAGEN-form NR administration that found no meaningful safety signal at the doses tested over an extended period.

A Nine-Year-Old Retriever and What “Long Term” Actually Means

A client of mine had a 62-pound golden retriever, nine years old, who’d started an NAD+ precursor chew after a bloodwork panel came back otherwise clean. The question wasn’t whether to try it — it was whether to keep going. By week six, the owner reported the dog was initiating play again in the evenings, something he’d stopped doing months earlier. That’s a real observation and a useful one. But it’s also exactly the kind of change that’s hard to separate from other variables — a diet adjustment, warmer weather, a joint supplement started around the same time. I told her: keep the chew if you want to, but don’t stop watching everything else just because one thing improved.

Where the Long-Term Safety Picture Gets Thinner

Here’s the honest gap: there is no multi-year canine safety study on NAD+ precursors that I can point you to. The 2024 Scientific Reports trial and the human long-term data are reassuring as far as they go, but “as far as they go” is still a matter of months, not years, in dogs specifically. Nicotinamide riboside itself is closely related to niacin (vitamin B3), and the NIH Office of Dietary Supplements fact sheet on niacin is worth reading if you want the underlying nutrient context, since NR is metabolized through overlapping pathways.

Related ingredients in this space carry their own caveats. Quercetin, often paired with NAD+ precursors in senior formulas, is a flavonoid studied for antioxidant and cellular support properties, though the in vitro research is preliminary — one study found that Pharmaceuticals (DOI.3390/ph19040525): quercetin and related compounds, at the concentrations tested, did not affect feeding behavior in the model organism used, which tells you more about dosing thresholds than about clinical outcomes in dogs. Resveratrol has a similar profile: useful mechanistic interest, thin clinical translation. One in vitro study on a related compound found that embryonic exposure at a specific concentration accelerated developmental timing but shortened lifespan in the model organism — a reminder that “more antioxidant” isn’t automatically “better outcome,” and that Phytomedicine (DOI.1016/j.phymed.2026.158531): dose and timing matter more than the ingredient name.

An Edge Case That Changes How I’d Advise You

Not every older dog is a clean case. I worked with a 13-year-old dachshund, 22 pounds, with early kidney values trending upward on routine senior panels but no other symptoms. Her owner wanted to start an NAD+ precursor for general vitality. I didn’t say no — but I said we’d need bloodwork at 8 weeks instead of the usual “check in a few months,” because any new supplement in a dog with borderline organ values deserves tighter monitoring, not looser. That’s the piece people skip: long-term safety isn’t just about the ingredient in isolation, it’s about the specific dog carrying it, and what else that dog’s body is already managing.

Where I Land

I’m comfortable with NAD+ precursors as a reasonable, evidence-informed option for healthy senior dogs, used alongside — never instead of — a veterinary relationship that includes regular bloodwork. What I’m not comfortable with is the framing that shows up in a lot of marketing copy, where “long term” gets used as if it were synonymous with “proven safe for years.” It isn’t, yet. The strongest counterargument to my position is that the ingredient class overlaps heavily with niacin, which does have a long human safety record — and that’s fair. But dogs aren’t small humans metabolically, and I’d rather a family start cautiously with lab monitoring than assume the human data closes the question for their dog.

If you want to understand a related piece of this landscape, how long nicotinamide riboside takes to actually raise NAD+ levels in dogs is worth reading before you commit to a long-term plan. The same goes for what the evidence shows about NAD+ and a dog’s brain specifically, and if cognition is your primary concern, our broader look at supplements for an aging dog’s mental sharpness puts NAD+ in context next to other options.

The bottom line I give families in the exam room: this is a piece of information gathering, not a verdict. Watch the dog, not just the supplement.